Allspring Global Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101M | Buy |
312,216
+41,292
| +15% | +$13.3M | 0.17% | 147 |
|
|
2025
Q1 | $69.3M | Buy |
+270,924
| New | +$69.3M | 0.12% | 208 |
|
|
2024
Q4 | – | Sell |
-420
| Closed | -$116K | – | 1773 |
|
|
2024
Q3 | $116K | Buy |
420
+161
| +62% | +$44.3K | ﹤0.01% | 1763 |
|
|
2024
Q2 | $62.9K | Buy |
259
+91
| +54% | +$22.1K | ﹤0.01% | 1932 |
|
|
2024
Q1 | $25.1K | Buy |
168
+143
| +572% | +$21.4K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $4.79K | Sell |
25
-77,988
| -100% | -$14.9M | ﹤0.01% | 2051 |
|
|
2023
Q3 | $13.8M | Buy |
78,013
+50,124
| +180% | +$8.88M | 0.02% | 648 |
|
|
2023
Q2 | $5.3M | Sell |
27,889
-6,492
| -19% | -$1.23M | 0.01% | 978 |
|
|
2023
Q1 | $6.89M | Sell |
34,381
-2,887
| -8% | -$578K | 0.01% | 901 |
|
|
2022
Q4 | $8.86M | Sell |
37,268
-246
| -0.7% | -$58.5K | 0.02% | 808 |
|
|
2022
Q3 | $7.51M | Sell |
37,514
-1,603
| -4% | -$321K | 0.01% | 865 |
|
|
2022
Q2 | $5.7M | Sell |
39,117
-851
| -2% | -$124K | 0.01% | 952 |
|
|
2022
Q1 | $6.53M | Buy |
39,968
+14,121
| +55% | +$2.31M | 0.01% | 1036 |
|
|
2021
Q4 | $4.38M | Buy |
+25,847
| New | +$4.38M | ﹤0.01% | 1225 |
|